devie medical GmbH

Operation name
2018 FE 0032
Operation summary
Development of a drug-releasing catheter-based prosthetic cardiac valve for minimally invasive prophylaxis and treatment of a bacterial cardiac valve inflammation.
Operation start date
04.09.2018
Operation end date
31.08.2021
Total eligible expenditure allocated to the operation
921.114,07
Union co-financing rate
80 %
Operation postcode
07743
Country
Deutschland
Name of category of intervention
064 - Research and innovation processes in SMEs (including voucher programmes, innovations in the areas of operations, design, and service, as well as social innovations)